Improving diagnosis and treatment of Alzheimer's disease through advanced protein analysis
Next Generation Translational Proteomics for Alzheimer's and Related Dementias
This study is looking at special proteins in the fluid around your brain to help us understand and treat Alzheimer's disease better, so we can create more personalized care for each person.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10792929 on NIH RePORTER |
What this research studies
This research focuses on enhancing the understanding and treatment of Alzheimer's disease by analyzing cerebrospinal fluid (CSF) for specific proteins that indicate disease progression. A team of interdisciplinary experts will utilize cutting-edge technologies to identify biomarkers in CSF that reflect brain health and cognitive decline. By improving the molecular characterization of these biomarkers, the research aims to facilitate precision medicine approaches tailored to individual patients. This could lead to better monitoring of disease progression and responses to treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or related dementias who are seeking more effective monitoring and treatment options.
Not a fit: Patients with early-stage cognitive impairment that is not related to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and personalized treatment plans for patients with Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in using biomarkers in cerebrospinal fluid to monitor Alzheimer's disease, indicating that this approach has potential for significant advancements.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Maccoss, Michael — University of Washington
- Study coordinator: Maccoss, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.